UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Kinase Fusion Gene:TWF1_IRAK4 |
Kinase Fusion Protein Summary |
Kinase Fusion gene summary |
Kinase Fusion partner gene information | Kinase Fusion gene name: TWF1_IRAK4 | KinaseFusionDB ID: KFG6921 | FusionGDB2.0 ID: KFG6921 | Hgene | Tgene | Gene symbol | TWF1 | IRAK4 | Gene ID | 5756 | 51135 | |
Gene name | twinfilin actin binding protein 1 | interleukin 1 receptor associated kinase 4 | ||||||||||
Synonyms | A6|PTK9 | IMD67|IPD1|IRAK-4|NY-REN-64|REN64 | ||||||||||
Cytomap | 12q12 | 12q12 | ||||||||||
Type of gene | protein-coding | protein-coding | ||||||||||
Description | twinfilin-1A6 protein tyrosine kinasePTK9 protein tyrosine kinase 9protein A6protein tyrosine kinase 9twinfilin, actin-binding protein, homolog 1 | interleukin-1 receptor-associated kinase 4renal carcinoma antigen NY-REN-64 | ||||||||||
Modification date | 20240407 | 20240403 | ||||||||||
UniProtAcc | Q12792 | Q9NWZ3 | ||||||||||
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000552521, ENST00000325127, ENST00000395510, ENST00000547564, ENST00000548315, | ENST00000431837, ENST00000440781, ENST00000448290, ENST00000551736, | |||||||||
Context (manual curation of fusion genes in KinaseFusionDB) | PubMed: TWF1 [Title/Abstract] AND IRAK4 [Title/Abstract] AND fusion [Title/Abstract] | |||||||||||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | TWF1(44196089)-IRAK4(44180202), # samples:1 |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | TWF1 | GO:0043538 | regulation of actin phosphorylation | 10406962 |
Tgene | IRAK4 | GO:0038172 | interleukin-33-mediated signaling pathway | 11960013 |
Tgene | IRAK4 | GO:0070498 | interleukin-1-mediated signaling pathway | 20485341 |
Kinase Fusion gene breakpoints across TWF1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Kinase Fusion gene breakpoints across IRAK4 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Kinase Fusion Gene Sample Information |
Kinase Fusion gene information. |
Kinase Fusion gene information from four resources (ChiTars 5.0, ChimerDB 4.0, COSMIC, and CCLE) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Sample | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp |
ChimerDB4 | TCGA-BR-8296-01A | TWF1 | chr12 | 44196089 | IRAK4 | chr12 | 44180202 |
Top |
Kinase Fusion ORF Analysis |
Kinase Fusion information from ORFfinder translation from full-length transcript sequence from KinaseFusionDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Seq length (transcript) | Seq length (amino acids) |
Top |
Kinase Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from KinaseFusionDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>Henst_Tenst_Hgene_Hchr_Hbp_Tgene_Tchr_Tbp_length(fusion AA)_AAseq |
Multiple Sequence Alignment of All Fusion Protein Isoforms |
Top |
Kinase Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:44196089/chr12:44180202) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
TWF1 | IRAK4 |
FUNCTION: Actin-binding protein involved in motile and morphological processes. Inhibits actin polymerization, likely by sequestering G-actin. By capping the barbed ends of filaments, it also regulates motility. Seems to play an important role in clathrin-mediated endocytosis and distribution of endocytic organelles (By similarity). {ECO:0000250}. | FUNCTION: Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways (PubMed:17878374). Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation to form the Myddosome together with IRAK2. Phosphorylates initially IRAK1, thus stimulating the kinase activity and intensive autophosphorylation of IRAK1. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates NCF1 and regulates NADPH oxidase activation after LPS stimulation suggesting a similar mechanism during microbial infections. {ECO:0000269|PubMed:11960013, ECO:0000269|PubMed:12538665, ECO:0000269|PubMed:15084582, ECO:0000269|PubMed:17217339, ECO:0000269|PubMed:17337443, ECO:0000269|PubMed:17878374, ECO:0000269|PubMed:17997719, ECO:0000269|PubMed:20400509, ECO:0000269|PubMed:24316379}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained domain in the 5'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
- Retained domain in the 3'-partner of fusion protein (protein functional feature from UniProt). |
Partner | Hgeneene | Hbp | Tgeneene | Tbp | ENST | BPexon | TotalExon | Protein feature loci | BPloci | TotalLen | Feature | Note |
Top |
Kinase-Substrate Information of TWF1_IRAK4 |
Phosphorylation target of the kinase (phosphosite, 03-17-2024) |
Kinase | Kinase UniProt Acc | Kinase species | Substrate | Substrate UniProt Acc | Substrate phosphorylated residues | Substrate phosphorylated sites (+/-7AA) | Domain |
IRAK4 | Q9NWZ3 | human | PELI1 | Q96FA3 | T80 | DQHsIsYtLsRAQtV | Pellino |
IRAK4 | Q9NWZ3 | human | NCF1 | P14598 | S348 | PGPQsPGsPLEEERQ | |
IRAK4 | Q9NWZ3 | human | IRAK4 | Q9NWZ3 | T345 | kFAQtVMtsRIVGTt | PK_Tyr_Ser-Thr |
IRAK4 | Q9NWZ3 | human | PELI1 | Q96FA3 | T288 | QCPVGFNtLAFPsMk | Pellino |
IRAK4 | Q9NWZ3 | human | PELI1 | Q96FA3 | T127 | GSQSNsDtQSVQSTI | Pellino |
IRAK4 | Q9NWZ3 | human | NCF1 | P14598 | T356 | PLEEERQtQRsKPQP | |
IRAK4 | Q9NWZ3 | human | NCF1 | P14598 | S320 | QRsRKRLsQDAYRRN | NECFESHC |
IRAK4 | Q9NWZ3 | human | IRAK1 | P51617 | S376 | GSsPsQssMVARtQT | Pkinase |
IRAK4 | Q9NWZ3 | human | IRAK4 | Q9NWZ3 | T209 | KGYVNNttVAVKKLA | PK_Tyr_Ser-Thr |
IRAK4 | Q9NWZ3 | human | IRAK4 | Q9NWZ3 | S8 | MNkPItPsTYVRCLN | |
IRAK4 | Q9NWZ3 | human | IRAK4 | Q9NWZ3 | S346 | FAQtVMtsRIVGTtA | PK_Tyr_Ser-Thr |
IRAK4 | Q9NWZ3 | human | NCF1 | P14598 | S370 | PAVPPRPsADLILNR | p47_phox_C |
IRAK4 | Q9NWZ3 | human | PELI1 | Q96FA3 | S82 | HsIsYtLsRAQtVVV | Pellino |
IRAK4 | Q9NWZ3 | human | IRAK4 | Q9NWZ3 | T342 | AsEkFAQtVMtsRIV | PK_Tyr_Ser-Thr |
IRAK4 | Q9NWZ3 | human | IRAK4 | Q9NWZ3 | T352 | tsRIVGTtAYMAPEA | PK_Tyr_Ser-Thr |
IRAK4 | Q9NWZ3 | human | PELI1 | Q96FA3 | S70 | PQAAKAIsNKDQHsI | Pellino |
IRAK4 | Q9NWZ3 | human | NCF1 | P14598 | S288 | QKsGQDVsQAQRQIK | NECFESHC |
IRAK4 | Q9NWZ3 | human | NCF1 | P14598 | T153 | KSTATDItGPIILQT | |
IRAK4 | Q9NWZ3 | human | IRAK1 | P51617 | T387 | RtQTVRGtLAYLPEE | Pkinase |
IRAK4 | Q9NWZ3 | human | IRAK4 | Q9NWZ3 | T208 | YKGYVNNttVAVKKL | PK_Tyr_Ser-Thr |
IRAK4 | Q9NWZ3 | human | PELI1 | Q96FA3 | S78 | NKDQHsIsYtLsRAQ | Pellino |
IRAK4 | Q9NWZ3 | human | PELI1 | Q96FA3 | T86 | YtLsRAQtVVVEYTH | Pellino |
IRAK4 | Q9NWZ3 | human | NCF1 | P14598 | S345 | QARPGPQsPGsPLEE | |
IRAK4 | Q9NWZ3 | human | NCF1 | P14598 | T133 | KLPTDNQtKKPEtyL | |
IRAK4 | Q9NWZ3 | human | NCF1 | P14598 | T138 | NQtKKPEtyLMPKDG | |
IRAK4 | Q9NWZ3 | human | IRAK4 | Q9NWZ3 | T6 | __MNkPItPsTYVRC | |
IRAK4 | Q9NWZ3 | human | IRAK4 | Q9NWZ3 | S151 | SYMPPDsssPENKsL | |
IRAK4 | Q9NWZ3 | human | PELI1 | Q96FA3 | S293 | FNtLAFPsMkRkDVV | Pellino |
IRAK4 | Q9NWZ3 | human | IRAK4 | Q9NWZ3 | S152 | YMPPDsssPENKsLE | |
IRAK4 | Q9NWZ3 | human | IRAK4 | Q9NWZ3 | S114 | KTANTLPskEAITVQ | |
IRAK4 | Q9NWZ3 | human | PELI1 | Q96FA3 | S76 | IsNKDQHsIsYtLsR | Pellino |
IRAK4 | Q9NWZ3 | human | IRAK4 | Q9NWZ3 | S150 | QSYMPPDsssPENKs | |
IRAK4 | Q9NWZ3 | human | NCF1 | P14598 | S359 | EERQtQRsKPQPAVP | p47_phox_C |
Biological Network Integration of This Kinase and Substrates (GeneMANIA website) |
Enriched GO biological processes of the phosphorylation target genes of the kinase |
Kinase | GOID | GO term | P.adjust |
IRAK4 | ID | Description | 0.00e+00 |
IRAK4 | GO:0008063 | Toll signaling pathway | 1.26e-07 |
IRAK4 | GO:0140894 | endolysosomal toll-like receptor signaling pathway | 5.39e-06 |
IRAK4 | GO:0034142 | toll-like receptor 4 signaling pathway | 6.64e-06 |
IRAK4 | GO:0140895 | cell surface toll-like receptor signaling pathway | 7.54e-06 |
IRAK4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway | 8.31e-06 |
IRAK4 | GO:0045088 | regulation of innate immune response | 9.01e-06 |
IRAK4 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway | 1.32e-05 |
IRAK4 | GO:0002753 | cytosolic pattern recognition receptor signaling pathway | 4.81e-05 |
IRAK4 | GO:0007254 | JNK cascade | 5.95e-05 |
IRAK4 | GO:0043123 | positive regulation of canonical NF-kappaB signal transduction | 9.33e-05 |
IRAK4 | GO:0034162 | toll-like receptor 9 signaling pathway | 1.11e-04 |
IRAK4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 1.11e-04 |
IRAK4 | GO:0051403 | stress-activated MAPK cascade | 1.11e-04 |
IRAK4 | GO:0002221 | pattern recognition receptor signaling pathway | 1.11e-04 |
IRAK4 | GO:0031098 | stress-activated protein kinase signaling cascade | 1.11e-04 |
IRAK4 | GO:0002758 | innate immune response-activating signaling pathway | 1.29e-04 |
IRAK4 | GO:0043122 | regulation of canonical NF-kappaB signal transduction | 1.36e-04 |
IRAK4 | GO:0002218 | activation of innate immune response | 1.45e-04 |
IRAK4 | GO:0007249 | canonical NF-kappaB signal transduction | 1.76e-04 |
IRAK4 | GO:0070498 | interleukin-1-mediated signaling pathway | 1.78e-04 |
IRAK4 | GO:0002429 | immune response-activating cell surface receptor signaling pathway | 1.90e-04 |
IRAK4 | GO:0045089 | positive regulation of innate immune response | 2.18e-04 |
IRAK4 | GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 2.18e-04 |
IRAK4 | GO:0032496 | response to lipopolysaccharide | 2.18e-04 |
IRAK4 | GO:0030522 | intracellular receptor signaling pathway | 2.18e-04 |
IRAK4 | GO:0002237 | response to molecule of bacterial origin | 2.31e-04 |
IRAK4 | GO:0002833 | positive regulation of response to biotic stimulus | 2.31e-04 |
IRAK4 | GO:0002757 | immune response-activating signaling pathway | 4.67e-04 |
IRAK4 | GO:0031349 | positive regulation of defense response | 4.72e-04 |
IRAK4 | GO:0002764 | immune response-regulating signaling pathway | 5.15e-04 |
IRAK4 | GO:0002224 | toll-like receptor signaling pathway | 6.22e-04 |
IRAK4 | GO:0048661 | positive regulation of smooth muscle cell proliferation | 1.06e-03 |
IRAK4 | GO:0071347 | cellular response to interleukin-1 | 1.32e-03 |
IRAK4 | GO:0070555 | response to interleukin-1 | 2.03e-03 |
IRAK4 | GO:0048660 | regulation of smooth muscle cell proliferation | 2.95e-03 |
IRAK4 | GO:0048659 | smooth muscle cell proliferation | 3.00e-03 |
IRAK4 | GO:0071222 | cellular response to lipopolysaccharide | 4.86e-03 |
IRAK4 | GO:0071219 | cellular response to molecule of bacterial origin | 5.28e-03 |
IRAK4 | GO:0033002 | muscle cell proliferation | 5.50e-03 |
IRAK4 | GO:0071216 | cellular response to biotic stimulus | 6.16e-03 |
IRAK4 | GO:0045860 | positive regulation of protein kinase activity | 6.80e-03 |
IRAK4 | GO:0033674 | positive regulation of kinase activity | 9.45e-03 |
IRAK4 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway | 1.15e-02 |
IRAK4 | GO:1903037 | regulation of leukocyte cell-cell adhesion | 1.16e-02 |
IRAK4 | GO:0071394 | cellular response to testosterone stimulus | 1.20e-02 |
IRAK4 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway | 1.27e-02 |
IRAK4 | GO:0051347 | positive regulation of transferase activity | 1.27e-02 |
IRAK4 | GO:0007159 | leukocyte cell-cell adhesion | 1.27e-02 |
IRAK4 | GO:0002679 | respiratory burst involved in defense response | 1.44e-02 |
Top |
Related Drugs to TWF1_IRAK4 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Distribution of the number of studies mentioning TWF1-IRAK4 and kinase inhibitors the PubMed Abstract (04-01-2024) |
Fusion gene - drug pair 1 | Fusion gene - drug pair 2 | PMID | Publication date | DOI | Study title |
Top |
Related Diseases to TWF1_IRAK4 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Related diseases from the literature mentioned this fusion gene and drug. (PubMed, 04-01-2024) |
MeSH ID | MeSH term |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Top |
Clinical Trials of the Found Drugs/Small Molecules |
Statistics of the Clinical Trials of the Found Kinase Inibitors from clinicaltrials.gov (06-17-2024) |
Clinical Trials from clinicaltrials.gov (06-17-2024) |
Fusion Gene | Kinase Inhibitor | NCT ID | Study Status | Phases | Disease | # Enrolment | Date |